Skip to main content
. 2019 Dec 3;110(12):3754–3760. doi: 10.1111/cas.14218

Figure 1.

Figure 1

Accrual and treatment summary of patients in the present study. 5‐FU, fluorouracil; CDDP, cisplatin; DCF, docetaxel, cisplatin, plus 5‐fluorouracil therapy; GI, gastrointestinal; PD, progression of disease